Neurocrine Biosciences, Inc.
(NASDAQ : NBIX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -0.29%332.640.0%$4440.11m
BNTXBioNTech SE 2.11%268.400.0%$738.48m
NVAXNovavax, Inc. -15.72%135.3179.4%$599.29m
AMGNAmgen, Inc. 1.52%209.921.4%$554.61m
SNSSSunesis Pharmaceuticals, Inc. 3.75%6.370.7%$445.29m
REGNRegeneron Pharmaceuticals, Inc. 1.60%560.922.7%$438.47m
GILDGilead Sciences, Inc. 0.28%67.091.0%$414.23m
CCXIChemoCentryx, Inc. 3.09%34.692.9%$397.26m
ILMNIllumina, Inc. -0.18%413.363.3%$373.97m
XLRNAcceleron Pharma, Inc. -0.47%172.925.3%$348.67m
VRTXVertex Pharmaceuticals, Inc. 0.38%186.121.9%$270.79m
BIIBBiogen, Inc. -0.73%266.181.7%$241.76m
OCGNOcugen, Inc. 5.16%8.760.0%$185.52m
XENEXenon Pharmaceuticals, Inc. 2.21%30.470.4%$163.92m
CRSPCRISPR Therapeutics AG -1.63%98.630.6%$159.49m

Company Profile

Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company. It discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine related diseases and disorders. The firm's product includes INGREZZA. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.